510(k) Submission for FDA Clearance
Substantial equivalence, predicate logic, and evidence alignment determine 510(k) clearance success
Key Outcomes
Clear predicate and substantial equivalence rationale
Claims, labeling, and indications aligned with design and risk
Lower deficiency risk and faster review cycles
Submission package structured for efficient FDA review
Medical device companies seeking 510(k) clearance must demonstrate substantial equivalence through a structured regulatory submission that aligns predicate selection, intended use, technological characteristics, and evidence requirements. The process looks simple on paper, but many sponsors encounter avoidable deficiencies because their testing strategy, labeling, or comparison rationale does not match FDA review expectations. Clear alignment between device functionality, claims, and predicate device analysis determines whether FDA deems a device substantially equivalent and ready for US market entry.
UnifiMed builds a comprehensive 510(k) submission framework that connects regulatory logic, clinical considerations, and testing strategy to support a predictable, efficient review.
CHALLENGES
Common 510(k) Submission Failures
Across early-stage and established MedTech manufacturers, several recurring issues delay 510(k) clearance and generate additional FDA questions
Weak or incomplete predicate device analysis that undermines the substantial equivalence rationale
Intended use and indications that stretch beyond what bench, biocompatibility, or clinical evidence can support
Evidence gaps in biocompatibility, sterilization, bench performance, software, or electrical safety testing
Inadequate documentation of technological characteristics relative to the predicate device
Labeling, IFUs, and marketing language that conflict with substantial equivalence assertions
Disorganized 510(k) summaries and submission narratives that slow FDA review and trigger clarification requests
These gaps increase review time, reduce predictability, and delay U.S. market clearance
OUR PROCESS
How We Structure a 510(k) Regulatory Submission
UnifiMed develops a 510(k) submission architecture that supports substantial equivalence, reduces deficiency risk, and strengthens FDA interactions
Predicate Device and Substantial Equivalence Strategy
We assess whether the 510(k) pathway is appropriate and identify the predicate devices that most credibly support substantial equivalence. Intended use, technological characteristics, and differences are evaluated and documented to establish a defensible regulatory foundation
Device Description and Technological Characteristics
We develop a clear, FDA-ready device description that anchors the equivalence argument. Technological characteristics and differences are defined in a way that aligns with risk controls and testing evidence
Testing and Performance Evidence Planning
We define a testing strategy aligned with FDA guidance, device risk, and applicable standards. Bench, biocompatibility, electrical safety, software, and usability requirements are scoped to support safety and performance equivalence
Risk Management and Software Documentation Integration
We align ISO 14971 risk documentation and, where applicable, software and cybersecurity evidence with the substantial equivalence narrative. Residual risks and technological differences are justified to confirm no new safety or effectiveness concerns
Labeling, Indications, and Claims Alignment
We ensure intended use, indications, and claims remain fully supported by the predicate pathway and submitted evidence. Labeling is reviewed to prevent overstatement that could trigger FDA questions or reclassification
Submission Assembly and FDA Interaction Planning
We assemble the complete 510(k) submission using current FDA format expectations and reviewer navigation standards. FDA interaction planning is built in to anticipate questions, streamline responses, and support predictable clearance timelines
Ready to Learn More?
Contact our team to discuss how we can support your 510(k) regulatory submission